Evidence map›Paper›PMID 34543656›Full record

ReviewBiochemical pharmacology2021

Applications and evolution of melittin, the quintessential membrane active peptide.

Shantanu Guha, Ryan P Ferrie, Jenisha Ghimire, Cristina R Ventura, Eric Wu, Leisheng Sun, Sarah Y Kim, Gregory R Wiedman, Kalina Hristova, Wimley C Wimley

Open access · greenAbstract readReview
In one paragraph

Review in Biochemical pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 139 citations in OpenAlex.

  1. Combination of Melittin andInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. In Vitro Antitumor Effects of Melittin Attached to FeMolecules (Basel, Switzerland) · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Genome of venomous caterpillarProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  16. Article
  17. BoltzGen: Toward Universal Binder Design.bioRxiv : the preprint server for biology · 2025
    Article
  18. Article
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Shantanu GuhaUniversity of Texas Health Science Center at Houston, Department of Microbiology and Molecular Genetics, Houston, TX, USA.
Ryan P FerrieTulane University School of Medicine, Department of Biochemistry and Molecular Biology, New Orleans, LA, USA.
Jenisha GhimireTulane University School of Medicine, Department of Biochemistry and Molecular Biology, New Orleans, LA, USA.
Cristina R VenturaSeton Hall University, Department of Chemistry and Biochemistry, South Orange, NJ, USA.
Eric WuTulane University School of Medicine, Department of Biochemistry and Molecular Biology, New Orleans, LA, USA.
Leisheng SunTulane University School of Medicine, Department of Biochemistry and Molecular Biology, New Orleans, LA, USA.
Sarah Y KimDuke University, Department of Biomedical Engineering, Durham, NC, USA.
Gregory R WiedmanSeton Hall University, Department of Chemistry and Biochemistry, South Orange, NJ, USA.
Kalina HristovaJohns Hopkins University, Department of Materials Science and Engineering, Baltimore, MD, USA. Electronic address: kalina.hristova@jhu.edu.
Wimley C WimleyUniversity of Texas Health Science Center at Houston, Department of Microbiology and Molecular Genetics, Houston, TX, USA. Electronic address: wwimley@tulane.edu.
Tulane University · USSeton Hall University · USThe University of Texas Health Science Center at Houston · USDuke University · USJohns Hopkins University · US

Funding

Spontaneous Membrane Translocating PeptidesR01GM111824 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI WIMLEY, WILLIAM C · 2016 to 2019
$1.4M
Mechanism of Resistance Avoidance in Synthetically Evolved Antibacterial PeptidesR21AI154284 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI WIMLEY, WILLIAM C · 2021 to 2022
$418k
NIAID NIH HHS R21 AI154284NIGMS NIH HHS R01 GM111824
6 · The paper itself

Abstract

Melittin, the main venom component of the European Honeybee, is a cationic linear peptide-amide of 26 amino acid residues with the sequence: GIGAVLKVLTTGLPALISWIKRKRQQ-NH

Indexed as

AnimalsBeesGene Expression RegulationMelittenPhylogenyProtein ConformationMelitten

Identifiers

PMID34543656
PMCPMC9235364
OpenAlexW3201247399

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.